封面
市場調查報告書
商品編碼
1575809

全球溶血卵磷脂市場 - 2024-2031

Global Lysolecithin Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 215 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球溶血卵磷脂市場在2023年達到1.575億美元,預計2031年將達到2.843億美元,2024-2031年預測期間複合年成長率為7.7%。

溶血卵磷脂具有獨特的特性,包括其形成膠束和脂質體的能力,使其成為藥物傳輸系統的有前途的選擇。研究人員正在研究溶血卵磷脂封裝和運輸各種活性藥物成分的潛力,旨在提高其生物利用度和治療效果。

此外,該行業的主要參與者推出的創新產品將推動該市場的成長。例如,建明工業公司推出了LYSOFORTE,這是一種源自溶血磷脂的營養乳化劑,專門用於增強畜禽飼料中脂肪、油和脂溶性營養素等高能量飼料成分的消化和吸收。其創新配方最佳化了脂肪消化的三個重要階段:乳化、水解和吸收。

動力學

消費者對健康益處的認知不斷提高

全球溶血卵磷脂市場的需求由多種因素驅動。關鍵因素之一是消費者對健康益處的認知不斷提高。消費者對溶血卵磷脂健康益處的認知正在顯著影響其融入多個行業的各種產品,特別是在全球市場。研究表明,溶血卵磷脂可以改善大腦健康和認知功能,從而吸引那些想要提高思維清晰度和記憶力的消費者,尤其是老年人群。

人們對天然和非基因改造成分的日益青睞使得溶血卵磷脂成為清潔標籤產品的首選。注重健康的消費者擴大尋找含有熟悉成分且符合其飲食選擇的產品。溶血卵磷脂的適應性使其能夠融入多個領域的各種產品中,包括食品和飲料、營養保健品和個人護理品。

生物技術和生命科學領域的不斷進步和創新為溶血卵磷脂的使用創造了新的機會,特別是在醫藥和健康相關產品領域。隨著消費者健康意識的增強,對具有針對性健康益處的功能性食品和膳食補充劑的需求顯著增加。

此外,該行業的主要參與者產品發布和關鍵開發將推動該市場的成長。例如,2023年8月,日興化學推出了Nikkol Lecinol MFL,該產品旨在透過刺激神經醯胺和聚絲蛋白的產生來增強皮膚的屏障功能。這種成分富含溶血磷脂酸,這是一種溶血卵磷脂,以其對錶皮細胞的廣泛功效而聞名。

藥物配方數量不斷增加

隨著藥物開發的不斷進步,溶血卵磷脂因其作為乳化劑、增溶劑和穩定劑的特性而越來越受歡迎,這對於提高藥物輸送系統的有效性至關重要。製藥業不斷開發新的配方,需要提高活性成分的生物利用度、控制釋放和增強吸收。

溶血卵磷脂是一種天然磷脂,用於提高疏水性藥物的溶解度,使其成為各種藥物製劑的首選。它形成脂質體和穩定乳液的能力增強了藥物的傳遞和吸收,這在口服、局部和注射藥物應用中尤其重要。

隨著製藥市場對更複雜藥物配方的需求增加,對溶血卵磷脂等功能性成分的需求也增加。此外,個人化醫療的趨勢(通常涉及專門的藥物輸送系統)預計將促進溶血卵磷脂在市場上的使用。製藥公司正在利用溶血卵磷脂來創造更有效、對患者友善的藥物產品,從而推動全球溶血卵磷脂市場的成長。

更便宜的合成乳化劑的可用性

與溶血卵磷脂等天然替代品相比,聚山梨醇酯、甘油單酯和甘油二酯等合成乳化劑以較低的成本廣泛使用。這些合成乳化劑通常具有類似的功能優勢,例如改善食品、化妝品和藥品的質地、穩定性和保存期限。因此,尋求降低成本的製造商傾向於選擇這些價格較低的產品,而不是溶血卵磷脂,特別是在加工食品和大眾市場個人護理產品等價格敏感的市場。

此外,合成乳化劑的生產往往更具可擴展性,並且受農業供應鏈的影響較小,而農業供應鏈通常會影響天然溶血卵磷脂的可用性和定價。這進一步鞏固了合成乳化劑在市場上的地位,因為它們可以以一致的品質和數量生產,使它們比天然乳化劑更具優勢。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 消費者對健康益處的認知不斷提高
      • 藥物配方數量不斷增加
    • 限制
      • 更便宜的合成乳化劑的可用性
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 監管分析
  • 定價分析
  • 專利分析
  • SWOT分析
  • 供應鏈分析
  • 價值鏈分析
  • 進出口分析
  • 臨床試驗分析
  • 消費者分析
  • 永續性分析
  • 熱圖
  • B2B分析

第 6 章:按來源

  • 植物性
    • 大豆
    • 向日葵
    • 油菜籽(油菜籽)
  • 以動物為基礎
    • 天竺鼠
    • 牛科

第 7 章:按類型

  • 水解溶血卵磷脂
    • 水解液
    • 脫油解
  • 化學改質溶血卵磷脂
  • 其他

第 8 章:按形式

  • 粉末
  • 液體
  • 顆粒劑

第 9 章:按申請

  • 糖果點心
  • 麵包店
  • 食品補充劑
  • 動物飼料
  • 乳製品
  • 個人護理和化妝品
  • 植物性替代品
  • 其他

第 10 章:最終用戶

  • 食品和飲料
  • 藥品
  • 化妝品
  • 營養保健品

第 11 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章:公司簡介

  • Kemin Industries, Inc.
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Cargill, Inc.
  • Lipoid GmbH
  • Sternchemie GmbH & Co. KG
  • Alexmo Cosmetics
  • Cayman Chemical
  • Creative Biolabs
  • GlpBio Technology
  • Larodan AB
  • Biosynth Ltd

第 14 章:附錄

簡介目錄
Product Code: FB8686

Overview

The Global Lysolecithin Market reached US$ 157.5 million in 2023 and is expected to reach US$ 284.3 million by 2031, growing at a CAGR of 7.7% during the forecast period 2024-2031.

Lysolecithin possesses unique characteristics, including its capacity to form micelles and liposomes, which make it a promising option for drug delivery systems. Researchers are investigating the potential of lysolecithin to encapsulate and transport various active pharmaceutical ingredients, intending to enhance their bioavailability and therapeutic effectiveness.

Further, key players in the industry launching innovative products that would drive this market growth. For instance, Kemin Industries, Inc. introduced LYSOFORTE a nutritional emulsifier derived from lysophospholipids, specifically designed to enhance the digestion and absorption of energy-dense feed components such as fats, oils and fat-soluble nutrients in livestock and poultry diets. Its innovative formulation optimizes three essential stages of fat digestion: emulsification, hydrolysis and absorption.

Dynamics

Rising Consumer Awareness of Health Benefits

The demand for the global lysolecithin market is driven by multiple factors. One of the key factors is the rising consumer awareness of health benefits. Consumer awareness of lysolecithin's health benefits is significantly influencing its incorporation into various products across multiple sectors, particularly in the global market. Studies indicate that lysolecithin may improve brain health and cognitive function, making it appealing to consumers who want to boost mental clarity and memory, particularly within aging populations.

The growing preference for natural and non-GMO ingredients has made lysolecithin a favored option in clean-label products. Health-conscious consumers are increasingly looking for items with familiar ingredients that match their dietary choices. Lysolecithin's adaptability enables its incorporation into a wide variety of products across several sectors, including food and beverages, nutraceuticals and personal care.

Ongoing advancements and innovations in biotechnology and life sciences are creating new opportunities for the use of lysolecithin, especially in the areas of medicine and health-related products. As consumers grow more health-conscious, there is a significant rise in the demand for functional foods and dietary supplements that offer targeted health benefits.

Moreover, key players in the industry product launches and key developments that would drive this market growth. For instance, in August 2023, Nikko Chemicals launched Nikkol Lecinol MFL, a product aimed at enhancing the skin's barrier function by stimulating the production of ceramides and filaggrin. This ingredient is rich in lysophosphatidic acid, a type of lysolecithin known for its extensive efficacy on epidermal cells.

Increasing Number of Drug Formulations

As drug development continues to advance, lysolecithin is gaining popularity for its properties as an emulsifier, solubilizer and stabilizer, which are crucial in enhancing the effectiveness of drug delivery systems. The pharmaceutical industry is constantly developing new formulations that require improved bioavailability, controlled release and enhanced absorption of active ingredients.

Lysolecithin, being a natural phospholipid, is used to improve the solubility of hydrophobic drugs, making it a preferred choice in various drug formulations. Its ability to form liposomes and stabilize emulsions enhances the delivery and absorption of medications, which is particularly important in oral, topical and injectable drug applications.

As the demand for more complex drug formulations rises in the pharmaceutical market, the need for functional ingredients like lysolecithin increases. Furthermore, the trend toward personalized medicine, which often involves specialized drug delivery systems, is expected to boost the use of lysolecithin in the market. Pharmaceutical companies are leveraging lysolecithin to create more effective and patient-friendly drug products, thereby driving the global lysolecithin market's growth.

Availability of Cheaper Synthetic Emulsifiers

Synthetic emulsifiers such as polysorbates, mono- and diglycerides and others are widely available at lower costs compared to natural alternatives like lysolecithin. These synthetic emulsifiers often provide similar functional benefits, such as improving texture, stability and shelf life in food, cosmetic and pharmaceutical products. As a result, manufacturers seeking to reduce costs are inclined to choose these lower-priced options over lysolecithin, especially in price-sensitive markets like processed foods and mass-market personal care products.

Additionally, the production of synthetic emulsifiers tends to be more scalable and less affected by the agricultural supply chain, which often impacts the availability and pricing of natural lysolecithin. This further solidifies the position of synthetic emulsifiers in the market, as they can be produced at a consistent quality and quantity, giving them an edge over their natural counterparts.

Segment Analysis

The global lysolecithin market is segmented based on source, type, form, application, end-user and region.

Diverse Applications and Various Health Benefits of Soy

Soy lysolecithin has become a widely used emulsifier in various food products due to its ability to enhance texture, stability and shelf life. It plays a vital role across various sectors, including food, pharmaceuticals and cosmetics. With consumers increasingly favoring healthier and more natural products, the demand for soy lysolecithin is anticipated to keep rising, growing because of its diverse applications and various health benefits. This trend creates substantial opportunities for manufacturers and suppliers in the lysolecithin market.

Soy lysolecithin is being explored for its potential use in drug delivery systems. Its distinctive characteristics allow it to serve as an effective medium for encapsulating active pharmaceutical ingredients, thereby improving their bioavailability and therapeutic effectiveness. Moreover, key players in the industry introduce various products in multiple sectors and key developments that would propel this segment's growth in the market.

For instance, in January 2024, Cosphatec launched two new products, Cosphaderm E NGM Natural and Cosphaderm PA-12, that adhere to the COSMOS and NATRUE certification standards for natural and organic cosmetic ingredients. This launch underscores Cosphatec's dedication to providing sustainable and eco-friendly raw materials for the cosmetics industry. Cosphaderm E NGM Natural is a liquid lysolecithin derived from soybeans.

Lysolecithin is an enzymatically modified form of lecithin, where a fatty acid has been removed through enzymatic processing. This modification results in a product with enhanced properties compared to regular lecithin. Similarly, Amitex India introduced the AmiLife Enzymatically Hydrolyzed Soya Lecithin (E322). It is derived from non-GMO soy lecithin. Through enzymatic hydrolysis, this lecithin undergoes modification to optimize its functional properties, making it suitable for diverse applications in the food industry and animal nutrition sectors.

Geographical Penetration

Expansion of the Food Processing Industry in Asia-Pacific

The increasing consumer preference for natural and non-GMO ingredients in food products is a prominent trend, especially in countries like India and China. As consumers in these regions become more health-conscious, they actively seek products that align with their dietary choices. Lysolecithin, which is derived from soy lecithin, fulfills these demands as it is viewed as a healthier alternative to synthetic emulsifiers.

The rapid expansion of the food processing industry in the Asia-Pacific region is a major factor driving the demand for lysolecithin as an emulsifier. Lysolecithin is extensively utilized in various food products, including baked goods, dairy items and convenience foods. The increasing consumption of processed and ready-to-eat meals, fueled by changing lifestyles and urbanization, has further heightened the need for effective emulsifiers like lysolecithin.

As urbanization progresses and consumer habits shift towards more convenient food options, the role of lysolecithin in food formulations is expected to grow, catering to both manufacturers' requirements and consumers' desires for high-quality processed foods. There is a rising awareness of the health advantages associated with lysolecithin, such as its capacity to improve cognitive function, lower cholesterol levels and support liver health helps to propel this market growth in this region.

Key player strategies such as partnerships & collaborations and technological advancements would drive this market growth. For instance, Prathista Industries has introduced a non-hormonal and naturally occurring feed supplement known as Pro-Lyso (Lysolecithin), developed in collaboration with the Indian Institute of Chemical Technology (IICT) in Hyderabad. This innovative product utilizes established biotechnology processes to enhance animal nutrition, specifically targeting poultry and shrimp.

Competitive Landscape

Bifurcation of how emerging players and startups function in the market

Emerging players and startups play a crucial role in the evolving lysolecithin market. While established players dominate large portions of the market, newer entrants are bringing innovation, agility and unique business models that challenge traditional supply chains. Many startups work closely with academic or research institutions to leverage the latest technological advancements in enzymatic processing or sustainable production methods. By adopting cutting-edge processes, they can produce high-quality lysolecithin at lower costs or with enhanced functionality, giving them a competitive advantage.

Market Presence: While startups are only entering the market, emerging players have made a name for themselves with their current offerings.

Resources: While startups frequently work with a small amount of cash, emerging players usually have access to additional resources, such as supply chains and finance.

Innovation Focus: While emerging players expand on previously developed ideas, Startups are catering to the growing demand for plant-based foods, positioning their lysolecithin products as natural emulsifiers in plant-based meat, dairy alternatives and clean-label processed foods. These companies are branding themselves as enablers of sustainable, ethical food production.

Brand Recognition: While startups are still developing their reputation and recognition in the industry, emerging players already have a certain amount of brand awareness. Startups use digital platforms to build their brand identity, often focusing on ethical sourcing, sustainability and transparency.

The major global players in the market include Kemin Industries, Inc., Cargill, Inc., Lipoid GmbH, Sternchemie GmbH & Co. KG, Alexmo Cosmetics, Cayman Chemical, Creative Biolabs, GlpBio Technology, Larodan AB and Biosynth Ltd.

Aim of trial: The objectives of this study were to evaluate three different strategies of LYSO supplementation on feedlot performance, carcass characteristics, nutrient digestion and the longissimus fatty acid profile of Bos indicus and Bos indicus crosses and to validate an innovative environmental index named InComfort (InCl) as a tool to evaluate DMI during natural heat stress events in the course of conducting open dry-lot feedlot experiments.

Materials and methods: All procedures and protocols involving the use of animals were approved by the Ethics Committee on animal use of the Sao Paulo State University "Julio de Mesquita Filho" (UNESP; Protocol number: 016339/19).

Results: In experiment (1), no differences were detected for IBW (P = 0.791). The use of LYSO increased FBW (P = 0.022); however, no differences were detected among the LYSO phase-feeding treatments (P = 0.191). Conversely, a tendency was observed (P = 0.060) when NON was compared with the pairwise comparisons of the means (GRO). In experiment (2), a treatment X breed interaction was observed, in which CEA animals had a higher IBW (P < 0.001; 406.42 vs. 372.55 for CEA and NEL, respectively); however, no differences were detected for FBW (P = 0.223; data not shown). Moreover, NEL animals from FIN also had greater DMI (P < 0.05) than NON, GRO and ALL cohorts within the same genotype but did not differ from CEA in the ALL and GRO protocols.

Conclusion: Overall, feeding LYSO during growing period (GRO) and finishing period (FIN) enhanced feedlot performance and should lead to higher intakes during very hot days of the finishing feeding period.

Consumer Analysis

Consumer analysis in the lysolecithin market helps to understand the behavior, preferences and needs of the market's various consumer segments. This analysis focuses on identifying the main industries and end-users of lysolecithin, their purchasing drivers, key concerns and the factors influencing their decision-making processes.

Consumers, particularly in the food, cosmetics and nutraceutical industries, increasingly prefer products that are natural, minimally processed and free from artificial additives. Lysolecithin, derived from natural sources like soybeans and sunflower seeds, aligns well with this trend. Although lysolecithin is favored for its natural properties, price remains a critical factor, particularly for large-scale users in the food and feed industries. Fluctuations in the prices of raw materials can significantly impact consumer purchasing decisions.

Sustainability Analysis

Sustainability is becoming a central focus for companies operating in the lysolecithin market. As industries worldwide move toward environmentally responsible practices, the lysolecithin market is being shaped by efforts to address environmental, social and governance factors. Sustainability in this market encompasses several areas, such as responsible sourcing of raw materials, eco-friendly production processes, reducing carbon footprints and offering products that align with consumer demand for clean-label, natural ingredients.

Cargill has been working to end deforestation related to soy production for more than 20 years. They promote sustainable practices to meet the world's growing demand for soy in food, animal feed and biofuels driven by increasing nutritional needs, changing dietary habits and desire for fossil-fuel alternatives. Cargill's role in the soy supply chain comes with significant responsibility and they are keenly aware of the need to deliver customer solutions in a safe, responsible and sustainable way.

By Source

  • Plant Based
    • Soy
    • Sunflower
    • Rapeseed (Canola)
  • Animal Based
    • Guinea Pig
    • Bovine

By Type

  • Hydrolyzed Lysolecithin
    • Fluid Hydrolyzed
    • De-oiled Hydrolyzed
  • Chemically Modified Lysolecithin
  • Others

By Form

  • Powder
  • Liquid
  • Granules

By Application

  • Confectionery
  • Bakery
  • Food Supplements
  • Animal Feed
  • Dairy Products
  • Personal Care and Cosmetics
  • Plant Based Alternatives
  • Others

By End-User

  • Food and Beverage
  • Pharmaceuticals
  • Cosmetics
  • Nutraceuticals

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, Cosphatec launched two new products, Cosphaderm E NGM Natural and Cosphaderm PA-12, that adhere to the COSMOS and NATRUE certification standards for natural and organic cosmetic ingredients. This launch underscores Cosphatec's dedication to providing sustainable and eco-friendly raw materials for the cosmetics industry. Cosphaderm E NGM Natural is a liquid lysolecithin derived from soybeans.
  • In 2023, Prathista Industries introduced a non-hormonal and naturally occurring feed supplement known as Pro-Lyso (Lysolecithin), developed in collaboration with the Indian Institute of Chemical Technology (IICT) in Hyderabad. This innovative product utilizes established biotechnology processes to enhance animal nutrition, specifically targeting poultry and shrimp.
  • In July 2022, Amitex India introduced the AmiLife Enzymatically Hydrolyzed Soya Lecithin (E322). It is derived from non-GMO soy lecithin. Through enzymatic hydrolysis, this lecithin undergoes modification to optimize its functional properties, making it suitable for diverse applications in the food industry and animal nutrition sectors.

Why Purchase the Report?

  • To visualize the global lysolecithin market segmentation based on source, type, form, application, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the global lysolecithin market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global Lysolecithin market report would provide approximately 78 tables, 77 figures and 215 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Type
  • 3.3. Snippet by Form
  • 3.4. Snippet by Application
  • 3.5. Snippet by End-User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Consumer Awareness of Health Benefits
      • 4.1.1.2. Increasing Number of Drug Formulations
    • 4.1.2. Restraints
      • 4.1.2.1. Availability of Cheaper Synthetic Emulsifiers
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. SWOT Analysis
  • 5.6. Supply Chain Analysis
  • 5.7. Value Chain Analysis
  • 5.8. Import and Export Analysis
  • 5.9. Clinical Trial Analysis
  • 5.10. Consumer Analysis
  • 5.11. Sustainability Analysis
  • 5.12. Heat Maps
  • 5.13. B2B Analysis

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Plant Based*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Soy
    • 6.2.4. Sunflower
    • 6.2.5. Rapeseed (Canola)
  • 6.3. Animal Based
    • 6.3.1. Guinea Pig
    • 6.3.2. Bovine

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Hydrolyzed Lysolecithin*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Fluid Hydrolyzed
    • 7.2.4. De-oiled Hydrolyzed
  • 7.3. Chemically Modified Lysolecithin
  • 7.4. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Powder*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Liquid
  • 8.4. Granules

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Confectionery*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Bakery
  • 9.4. Food Supplements
  • 9.5. Animal Feed
  • 9.6. Dairy Products
  • 9.7. Personal Care and Cosmetics
  • 9.8. Plant Based Alternatives
  • 9.9. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Food and Beverage*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Pharmaceuticals
  • 10.4. Cosmetics
  • 10.5. Nutraceuticals

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. US
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. UK
      • 11.3.8.3. France
      • 11.3.8.4. Italy
      • 11.3.8.5. Spain
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. Australia
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Kemin Industries, Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Cargill, Inc.
  • 13.3. Lipoid GmbH
  • 13.4. Sternchemie GmbH & Co. KG
  • 13.5. Alexmo Cosmetics
  • 13.6. Cayman Chemical
  • 13.7. Creative Biolabs
  • 13.8. GlpBio Technology
  • 13.9. Larodan AB
  • 13.10. Biosynth Ltd

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us